In this Issue
In retina, staying current with the latest techniques and technologies is necessary.
Medical Editors’ Page
By Allen C. Ho, MD, and Robert L. Avery, MD
BUSINESS OF RETINA
Innovations in Retina
Targeting Tie-2 in patients with wet AMD or diabetic eye disease could allow clinicians to treat patients who have not responded to conventional therapies.
By Aron Shapiro; David Hollander, MD; and Lisa Smith
Presenters at the Wills Retina Update asked retina doctors to look to the past to treat some patients while also exploring how future innovations could change the field’s dynamics.
By Sundeep K. Kasi, MD
Coding for Retina
A review of changes that take effect this year.
By Riva Lee Asbell
Case report illustrates potential for complication with peeling.
By Lihteh Wu, MD
This presentation can be a tall order for the surgeon, but the suggestions offered here can make the task less daunting.
By Charles C. Wykoff, MD, PhD
A case report illustrates the importance of performing a systemic workup on all patients with posterior uveitis.
By Nora Muakkassa, MD, and Lana Rifkin, MD; edited by Heeral R. Shah, MD, and Jordana G. Fein, MD
Some benign choroidal nevi can demonstrate minimal and slow enlargement without becoming malignant.
By Timothy S. Fuller, MD, and Carol L. Shields, MD
A yearly visit relieves many Palauans from having to fly elsewhere for ophthalmic care.
By Mark R. Wieland, MD
High-powered noncontact diathermy can clear vitreous hemorrhage in vitrectomy for PDR.
By John D. Pitcher III, MD, and Omesh P. Gupta, MD, MBA
Recent updates bode well for the relevance of laser therapy in retina.
By Mahima Jhingan, MD; Komal Agarwal, MD; and Jay Chhablani, MD
Sometimes the best approach requires a winning combination.
By Thanos Papakostas, MD, and Yoshihiro Yonekawa, MD
The trend toward smaller surgical instruments has led most recently to the creation of 27-gauge surgery. But is it the be-all and end-all?
By Michael A. Klufas, MD, and Jason Hsu, MD
With the trend toward smaller-gauge surgical platforms, a solid understanding of the options is necessary for success.
By Rohit Ross Lakhanpal, MD, FACS
Steven Yeh, MD, is the M. Louise Simpson Associate Professor of Ophthalmology and Director of the Uveitis and Vasculitis Section at the Emory Eye Center in Atlanta, Ga.